Patología Molecular de las enfermedades raras
PatMol-ER
Washington University in St. Louis School of Medicine
San Luis, Estados UnidosPublicaciones en colaboración con investigadores/as de Washington University in St. Louis School of Medicine (2)
2024
-
Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial
The Lancet Diabetes and Endocrinology, Vol. 12, Núm. 10, pp. 725-734
1999
-
The myeloperoxidase system of human phagocytes generates N(ε)- (carboxymethyl)lysine on proteins: A mechanism for producing advanced glycation end products at sites of inflammation
Journal of Clinical Investigation, Vol. 104, Núm. 1, pp. 103-113